Hiroo Hasegawa1, Masumichi Saitou2, Shunsuke Yamauchi1, Daisuke Sasaki1, Yoshitaka Imaizumi3, Yasushi Miyazaki3, Katsunori Yanagihara1 (1.Lab Med. Nagasaki Univ Hospital., Nagasaki, Japan, 2.National Institute of Infectious Diseases, Tokyo, Japan, 3.Dept. Hematology, Nagasaki Univ Hospital, Nagasaki, Japan)
Session information
Poster Session
Fri.Oct,11
Poster Session 1-11 Malignant Lymphoma: HTLV-1/EBV/Others
Fri. Oct 11, 2019 5:40 PM - 6:15 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Kisato Nosaka (Department of Hematology, Kumamoto University Hospital)
Hiroo Katsuya1,2, Paola Miyazato1,3, Saiful Islam1,3, Benjy Yang1,3, Yuki Inada3,4, Misaki Matsuo1,3, Takaharu Ueno5, Masahito Tokunaga6, Hiroyuki Hata4, Makoto Yamagishi7, Junichi Fujisawa5, Toshiki Watanabe8, Kaoru Uchimaru7, Atae Utsunomiya6, Shinya Kimura2, Yorifumi Satou1,3 (1.Joint Research Center Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2.Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan, 3.International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan, 4.Division of Informative Clinical Sciences, Kumamoto University, Kumamoto, Japan, 5.Department of Microbiology, Kansai Medical University, Hirakata, Japan, 6.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 7.Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan, 8.Future Center Initiative, The University of Tokyo, Tokyo, Japan)
Asami Yamada1, Miho Watanabe1, Mikiko Izaki1, Miho Matsumoto1, Yoshitaka Inoue1, Junichiro Yasunaga2, Kisato Nosaka1, Keisuke Kataoka3, Seishi Ogawa4, Masao Matsuoka1 (1.Hematology, Rheumatology and Infectious Diseases, Kumamoto University, Kumamoto, Japan, 2.Virus Control, IFLMS, Kyoto University, Kyoto, Japan, 3.Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan, 4.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan)
Shingo Nakahata1, Chilmi Syahrul1, Tomonaga Ichikawa1, Tadashi Matsuura2, Gene Kurosawa3, Kazuhiro Morishita1 (1.Div. Tumor&Cellular Biochem., Dept. Med. Sci., Miyazaki Univ, Miyazaki, Japan, 2.Perseus Proteomics Inc., Tokyo, Japan, 3.Fujita Health University, Aichi, Japan)
Young-Sun Nam1,2, Keon-Il Im1, Nayoun Kim1, Yunejin Song1, Jun-Seok Lee1, Young-Woo Jeon1,2, Seok-Goo Cho1,2 (1.Institute for Translational Research and Molecular Imaging, The Catholic University of Korea, Seoul, Republic of Korea, 2.Department of Hematology, Catholic Blood and Marrow Transplantation Venter, Seoul St. Mary's Hospital, Seoul, Republic of Korea)
Hiroki Hosoi1,2, Akiko Nanbu2, Michelle Mok2, Takashi Sonoki1, Motomi Osato2,3 (1.Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan, 2.Cancer Science Institute of Singapore, National University of Singapore, Singapore, 3.Department of Pediatrics, National University of Singapore, Singapore)
Hepei Yuan, Momoko Nishikori, Yasuyuki Otsuka, Hiroshi Arima, Toshio Kitawaki, Akifumi Takaori-Kondo (Deparatment of Hematology and Oncology, Kyoto University, Kyoto, Japan)